Intellia Therapeutics Stock News & Updates
[WKN: A2AG6H | Symbol: NTLA]
Intellia Therapeutics (NTLA) - CRISPR Specialist Impresses with Strong Pipeline!
Business Driver: Intellia Therapeutics (NTLA) specializes in the treatment of genetic diseases, primarily...
Analysts' Top 5 Price Targets of October 6, 2025
Redcare Pharmacy [NL0012044747] Jefferies confirms Buy rating with a price target of €150 (82% price...
Intellia Therapeutics: Wells Fargo Sees 173% Growth Potential!
Intellia Therapeutics (NTLA) has made it to the list of the analysts' top 10 price targets. The biotech...
Analysts' Top 5 Price Targets of September 19, 2025
Befesa [LU1704650164] UBS starts coverage with Buy and a price target of €44 (58% upside potential)...
Markets in Reverse: Economic Concerns and Middle East Tensions Weigh on Sentiment Ahead of Fed Decision – Huawei Scores with AI Weather Model - Eli Lilly Plans Billion-Dollar Acquisition - WhatsApp Becomes Advertising Platform - Amazon Expands Prime Day - OpenAI Receives Billion-Dollar Contract from Pentagon - Jabil Benefits Massively from AI Boom - DAX Slips
The stock markets are currently showing weakness, burdened by disappointing economic data and ongoing...
Stocks in Action USA: Meta, Jabil, Intellia Therapeutics
Meta (META): WhatsApp becomes an advertising platform – the exploitation of a new revenue source begins!...
Moody’s Downgrade Sends Shockwaves Through the Financial Markets – Yields Rise, Tech Stocks Plummet. NVIDIA (+1.16%) Solidifies its AI Dominance. The DAX (+0.53%) is Stable. Defense Stocks are Taking the Lead!
A thunderclap on the US financial markets: The downgrade of the United States' creditworthiness by Moody’s...
Analysts' Top 5 Price Targets of March 5, 2025
AxoGen [US05463X1063]: JMP Securities reaffirms Buy rating and raises the price target from $20 to $26...
- ‹
- 1
- ›